Drapalin 20/1 Bafokeng Choice
November 7, 2022 | Flower Products by categories

Drapalin 20/1 Bafokeng Choice is an indica-dominant hybrid. It is a unique cross between the cultivar White Lemon and the strain Marakabei Local, native to Lesotho. Marakabei Local is an original, genetically unaltered landrace and has been a part of...

read more
Drapalin 24/1 Bafokeng Choice
October 12, 2022 | Flower Products by categories

Drapalin 24/1 Bafokeng Choice is an indica-dominant hybrid. It is a unique cross between the cultivar White Lemon and the strain Marakabei Local, native to Lesotho Marakabei Local is an indigenous, genetically unaltered landrace that has blended into...

read more
Drapalin 10/11 Batha Balanced
October 11, 2022 | Flower Products by categories

Drapalin 10/11 Batha Balanced is a balanced hybrid strain with a harmounious indica-sativa ratio. It is a cross from our internal genetic program between Bafokeng Choice and an early phenotype of Grape Cluster. The target with this strain was to emul...

read more
Drapalin 1/17 Maluti CBD
October 10, 2022 | Flower Products by categories

Drapalin 1/17 Maluti CBD is a distinctly indica-dominant hybrid of the cultivars Otto Kush and ACDC with minimal psychoactive properties and a high β-myrcene content. The purple hues on the leaves and buds, as well as the grape aroma, give this uniq...

read more
Meet the Team – Mosele Tsemane
July 29, 2022 | Company News

Meet Mosele, our Production Manager! Mosele is a qualified Engineer with Masters in Chemical Engineering. He is an extrovert who thrives off of working with people from different backgrounds. In 2019, Mosele started working at MG Health as a Producti...

read more
Our Facility
June 21, 2022 | Company News

MG Health started with Research and Development in 2018 and has proudly been producing world-class Medical Cannabis since 2020! Our flagship facility is nestled in the stunning hilltops of the Marakabei region that forms part of the breathtaking Malu...

read more
CBD Strain: Basotho Choice (M-5806)
June 9, 2022 | Company News Industry News

Get ready for the next MG Health product launch, introducing Basotho Choice, known internally as M-5806. M-5806 is a flexible strain with lower psychoactive properties, it comprises of about 80% indica and 20% Sativa. It has a high Beta-Myrcene conte...

read more
Qualifications and Validations
April 30, 2022 | Company News

The three pillars of GMP are efficacy, safety and quality. At MG Health the focus is on Quality by Design which begins with the inception of a potential new process or equipment piece and is followed through the entire life cycle. The User Requiremen...

read more
Staff Training
April 11, 2022 | Company News

At MG Health all newly appointed employees undergo training on Health and Safety, Human Resource policies and Security rules as part of their induction training for the whole site. An introduction in the form of basic cGMP (current Good Manufacturing...

read more
Research and Development
April 4, 2022 | Company News

MG Health has an R&D Department mandated to develop up-scalable Cannabis processing methods in line with current GMP guidelines. Part of this is to establish final product standards and specifications. R&D comprises of a Flower Division and a...

read more